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ABSTRACT
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive
disorders of adrenal steroidogenesis. The genes of the steroidogenic
enzymes and the mutations involved have been described. Deficiency of
the 21-hydroxylase (21-0H) enzyme is by far the most common form of
CAH which arises as a result of deletions or deleterious mutations in the
active gene (CYP21) located on chromosome 6p. Many different mutations
of the CYP21 gene cause varying degrees of impairment of 21-0H activity
that results in a spectrum of disease expression. There is no sharp limit
between the salt- wasting, the simple virilizing and the late onset forms.
The objective of our study was to determine the 21-0H deficiency mutation
defects and correlate the genotype with their phenotypic expression of the
disease.
We performed mutational analysis using PCR-ASOH (Polymerase Chain
Reaction - Allele Specific Oligonucleotide Hybridization) technique on six
patients who presented with ambiguous genitalia (AG) and or electrolyte
derangement as hyponatraemia and hyperkalaemia, suspected to have
CAH. The Val281 Leu and Pr030Leu mutations result in enzymes with 20-
60% of normal activity and both are associated with the non-classical form
of CAH. The Gln318stop mutation is categorized under the salt-wasting
type.
Among the six patients, three had Val281 Leu mutation, two had Pr030Leu
mutation and one had Gln318stop mutation. The three patients with
Val281 Leu mutation had presented with adrenal crises during infancy and
was classified as salt losers and treated with glucocorticoids and
mineralocorticoids. These 3 patients could well be the other 40% who are
• categorized as salt-losers. The two patients with Pr030Leu mutations have
normal male external genitalia and presented with hyponatraemia and
hyperkalaemia. Only one patient required mineralocorticoid therapy that
was given for about 5 months duration. Subsequently he had normal
electrolytes level even without mineralocorticoid therapy. The Gln318stop
mutation was identified in one patient who presented with ambiguous
genitalia and adrenal crises.
Our study showed that the patients with genotype Val281 Leu, Pr030Leu
and Gln318stop mutations correlated with their phenotype. The mutation
analysis of CYP21 gene proved to be a good complementary investigation
and supportive to the diagnosis and management of our CAH patients.
Key words:. ambiguous genitalia, congenital adrenal hyperplasia, CYP21
gene.
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INTRODUCTION
Ambiguous genitalia (AG) are one of the clinical presentations of
congenital adrenal hyperplasia (CAH). Congenital adrenal
hyperplasia is an autosomal recessive disease caused by loss
or severe decrease in the activity of 21-hydroxylase (21-0H).
This enzyme is one of the five enzymes necessary for cortisol
biosynthesis. Deficiency of the 21-0H is the most common form
of CAH accounting for 90-95% of all cases of CAH 1,6.
Congenital adrenal hyperplasia presents a wide spectrum of
clinical manifestations and patients are divided into 3 groups:
salt wasting (SW), simple virilizing (SV) and non-classical (NC).
Salt wasting patients manifest as neonatal electrolyte
disturbances together with virilization of external genitalia at
birth in girls and early pseudoprecocious puberty in boys, while
SV patients present the same manifestation as SW patients, but
without electrolyte disturbances. Non- classical patients present
with late onset symptoms of androgen excess, ranging from
progressive virilization and pseudoprecocious puberty in
childhood to menstrual disturbances, infertility and hirsutism in
adult women 2•
It was reported that more than 90% of cases of CAH are caused
by mutation of the CYP21 gene. 'This 21-0H (CYP21) gene is
located in the HLA class III gene region on chromosome 6p21.3
and consist of 10 exons 3 . Majority of the mutations on the
CYP21 gene are Val281 Leu and Pr030Leu. These mutations were
reported to result in 20-60% of normal enzyme activity and both
are associated with the non-classical form of CAH4 ,5.
AIM OF THE STUDY
To detect the presence of point mutations in Pr030Leu,
lIe172Asn & Val281 Leu of CYP21 gene
MATERIALS AND MtrTHODS
DNA extraction (non-phenol chloroform
standard procedure)
PCR-ASOH ($llele Specific Oligonucleotide
Hybridization) mutational analysis using PCR-
ASOH technique
['Y:":';;:]1{ a..\/ ln/ -lf.\
.{ tf\
xl
/\l
,.....'.''-........,i
\ :-,' \,,/
Blood samples were obtained from patients referred to Hospital
Universiti Sains Malaysia, Kelantan, Malaysia during 1995-2002. A
thorough clinical examination and hormonal analyses were
performed. A total of 52 samples included were suspected to have
CAH based on ambiguity of the external genitalia or electrolyte
im ba lances.
Polymerase Chain Reaction (PCR)
RESULTS
Figure 1: Presence of PCR product (873 bp) for Cyp21 gene
exon 1-3 using 2.0o/o aearose gel electrophoresis. Lane M :
100 bp DNA ladder, lane N : negative control, lane 1, 2 :
normal samples, lane 3,4,5,6:samples showing pCR
ampf ification products for CYP21 gene.
Figure 2: Dot blotting was performed using 1 pg genomic
DNA. The blot was hybridized with 100 pmol/ml of the
digoxigenin labeled antiphosphatase (DIG-AP) specific probe
from samples of patient 1-7. ASOH of PCR product from CAH
patients was performed with the probe corresponding to the
site exon. The status N: normal, P: patient.
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RESULTS
Figure 3: Pro30leu hybridization DNA samples. Dot blotting
was performed using 1 pg genomic DNA. The blot was
hybridized with 100 pmol /ml of the digoxigenin labeled
antiphosphatase (D|G-AP) specific probe pro3OLeu. ASOH of
PcR product from cAH patients was performed with the probe(Pro30Leu) corresponding to the site exon 1. The status N:
normal, P: patient.
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DISCUSSION
Majority of the mutations in the CYP21 gene in our patients
are val2j1 Leu and Pro3Oleu. These mutations were
reported to result in 20-60% of normal enzyme activity and
both are associated with the non-classical form of cAHa'i.
ln our study, we found that 3152 patients (s]%) have
val2]1 Leu while 2152 patients (3 8%) have pro3Oleu
respectively. No mutations were observed in lle172Asn
Patients with ValZB1 Leu presented with adrenal crisis during
infancy and were classified as salt wasting. Two patients
with Pro30Leu mutations have normal male externalgenitalia and presented with hyponatraemia and
hyperkalaemia. We did not identify any patient with 1172N
mutation which is known to result in clearly reduced
enzymatic activity. AbouI 1-2% of 1172N mutation is usually
associated with the SV form8'e.
our findings showed that patients with Pro30leu mutations
were associated with non-classical form of CAH whereas
Val2B1 Leu mutations were associated with salt wasting form
of "CAH
CONCLUSION
This study suggested that phenotypes are not always
concordant with the genotype in patients with Val2B 1 Leu
mutations diagnosed with CAH
12.
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Molecular Analysis in the management of Congenital Adrenal Hyperplasia (CAH) and
Ambiguous Genitalia
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Patients presenting with ambiguous genitalia (AG) often pose a dilemma to the attending
clinicians with regard to sex assignnrent. To avoid gender confusion in later life' it is
important to recognize the underlying cause, initiate treatment and appropriate sex
assignment as soon as possible. We present 3 case reports to illustrate the use of
fluorescence in-situ hybridization (FISH), chromosome karyotyping and SRY gene
identification in the evaluation o[ patients with AG. Current hormonal and imaging
studies for sex determination could be complemented by the application of chromosomal
and molecular genetic studies which provide rapid and reliable genetic diagnosis. Delay
in diagnosisand treatment may result in death due to undiagnosed adrenal crisis in case
of congenital adrenal hyperplasia (CAH) and wrong sex assignment with its tragic
consequences. Molecular study and determination of the SRY gene are additional tools
for the investigations of patients with AG arrd intersex disorders.
Key words: cong,enital. adrenal hltperplo.sia (CAL|), antbiguous g,enitalia (AG), sex
dete rmination re g io n-Y ( S RY ).
The word ambiguous means indeterminate,
doubtful or uncertain. The term ambiguous genitalia
(AG) describe external genitalia that do not conform
to that of male or female. This would include severe
hypospadias with or without palpable gonads or
micropenis'. Other description for such
abnormalities include enlarged phallus/clitoris,
scrotalisation of the labioscrotal folds, partial or
complete fusion of the labioscrotal folds, chordee,
urogenital sinus and blind vaginal pouch.
The problem in the management of a baby wittt
AG is not only sex determination and appropriate
assignment, it is also prompt recognition of underlying
INTRODUCTION
The issue of gender assignment causes anxiety
and the problem of acceptance on the part of tlre
parents. Patients with ambiguous genitalia should
be investigated in order to understand the underlying
pathology and to provide a rational approach to
management and sex assignment, Diagnosis is aided
by hormonal, i.maging studies and genetic
information. Crirrent clinical and hormonal
investigation protocols for sex determination can be
enhanced by the application of chromosomal and
molecular genetic studies using SRY gene.
1n
medical emergencies tltat rrtay be associated. The
clinician must must be cluick to detect lil'e-threltcning
adrenal crisis in case of salt losing congenital adrenal
hyperplasia (CAH)r, and initiate irnmecliate
investigations and managementr'7
The initial trealment goals include firstly,
determination of the appropriate sex of rearing as quickly
as possible. Secondly, establishment of definitive
diagnosis, which may take longer to achieve. To avoid
gender identification crisis, social, personality and
religious problems during adulthood, fbllow up cate attd
management is needed to ensure physical and
psychological developnrent concordant with the assigned
sexa.
Availability of specitic hormonal investigation
is limited. Conventionally, genetic sex is determirted by
chromosome karyotyping. The result is generally
available within one month but a prelirninary report may
be available within a week. Currently new methods are
available using molecular technology st-tch as
fluorescence in-situ hybridization (FfSH) using the X
(Figure 7) and Y (Figure 8) probes to identify the types
of chromatin present. Identification of SRY gene (Figure
9) is another of these new molecular techniques r.
Figure 7: Microphotography oJ FISH technique using
the chromosonte X probe (pDMXl) on interythuse cell,
uriow shows 2 sig,nctls oJ'the chromosome X
Muleculur Anal)'si.t in lhe nruntrgt'tttcttr ol ('onge'tritul Alrcnul tlS|te\ilu;iu (L)Atl) urul Anbiguotrs Cenitttlitt
'fhe SI{Y gene is the testis-determining gene
Iocated on the short ann of the Y chromosome. lt
initiates a cascade of events that ultimately lead to
testis ditt'erentiation. StLrdies shqlved that SRY gene
in an individual indicates the presence of testicular
tissues. The use of the SRY gene testing as a tool in
curnplementing horntonal, imaging studies in the
evaluation of children with AG is helpful. The result
carr be obtained in less than a week a. Decision on
geuder assignment and registration of birth of baby
can be made without much delay.
h'igure 8: Micrcphotogruphy oJ' FISFI technique u.ring
pllY. I probe. Arntw shovvs the specific Y chromosome.
Itigure 9: Pfuttogrttph oJ'unrpliJied multiplex PCR protluct's
u:;ing X, Y clvonosonte urul SRY gene specific PCR primers.
M- 100 bp DNA ludtler (nrurker)
I - DNA stttnple Ji'om 46 XY with the presence cf'SRY gene
(273 bp)
2 - DNA suntple.fium 46 XX in the absence oJ'the SRY g,ene
I - DNA .tuntple.fi'ont 16 XY with the ubsence t{ SRY gene
4 - Negutive control (withctut DNA)
l3
The aim of the study is to apply the ntolecular
studies to complement the investigations for the
genetic assignment of patients with ambiguous
genitalia by presenting 3 case reports.
METHODS
Three patients were referred to Hospital Kota
Bharu (HKB) and Hospital Universiti Sains Malaysia
(HUSM) for further management of arnbiguous
genitalia. Blood specimen of 3-5 ml from the patients
with ambiguous genitalia was collected in sodium
EDTA or lithium heparin container' Blood was
cultured for metaphase cells for cytogenetic and
FISH according to the standard protocol. Genontic
DNA was extracted and subjected to the PCR
analysis of SRY gene methods'6.
RESULTS 
,
Patient L, presented to Hospital Kota Bharu
(HKB) at 10 weeks of age with intermittent vorniting
Thr rn,t1l;,t nf hormonal int,e,stifl,ntion of the 3 patient5 are tabulated as.follows.
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OBJECTIVE and failure to thrive since birth. The patient, a product
ofa non-consanguineous marriage was bom full term by
spontaneous vaginal delivery at a district hospital with a
birth weight of 2.8 kg (25-50'h percentile), length 56 cm
(>97'r' percentile) and head circumference 33 cm (10-
25'r'percentile). She is the younge.st of 5 siblings and the
eldest sibling who wa.s a boy died at 17 days old of an
unknown cause. On examination she was mildly
clehydrated with a weight of 2.8 kg (<3d percentile)' She
was afebrile and the blood pressure was 60/40 mmHg'
No other abnormalities were detected apart from AG
with a prominent phallus measuring 2 cm. No gonads or
rugae were noted at the labioscrotal folds, which was
not hyperpigmented' There was a single orifice at the
base of the phallus. The baby was registered as a girl by
the parents as they were not aware of the ambiguity of
the extemal genitalia at that particular time.
The initial electrolYtes showed
hyponatraemia, hyperkalaemia, increased blood urea
and metabolic acidosis (Table I ). A diagnosis of salt-
losing CAH was made and she was started on
glucocorticoids and mineralocorticoids' The
hormonal investigations showed that l7 -
hydroxyprogesterone (17-OHP) and aldosterone
were elevated with normal cortisol level (Table l)'
Tbble I: **Re,sults obtained prior to lnmtoruil tlterapv
\4
Tests Normal Range Patient l Patient2 Patient 3
Sodium 135-l50 mmol/L 92 ll8 I 38*
Potassium 3.5 
- 
5.O mmol/L 7.4 8.2 5.5*
Blood urea 1.4 
- 
6.8 mmol/L I 1.O NA 5.7*
Standard
bicarbonate (HCOrl lA -25 mmol/L t2.o NA NA
l7-oHP
>2O ng/rnl
3 mth-5 Yr: uP tol.l nelml
33.2 ng/rnl(<o.7-2.s)
2.8 nrnol/I-t*(norrnal for age)
Cortisol 484 nmol/L(am : 139-5Ol) NA
67 nrnol/La(am:221-69O
om: llO-345)
ACTH ND 5Q-7 pg/mlCN: <37) ND
Testosterone NA
<2O ng/dl(no reference)
3-O nmol/L
adult female:
o.9-2.8
Aldosterone
>3,3OO pmol/L(l I l-860
omol/L)
NA
l,4OO pmol/L*
erect: I l0-860
supine : 3O-44O
Plasma renin
activity NA
NA
72.O nglrnl/h*
erect: I .3-4.O
sur:ine: O.l-2.4
I(aryotyping 46-x)< 46.XX 46.XX
SRY sene Not present Not present Not Dresent
Ultrasouhd
(Jterus and
ovarles IJterus
(Jterus. Bilateral
pelvi-calyceal
system dilatation-
Mildly distended
bladder.
Genitogram Figure 3 Fisure 5 ND
* Patient u,as on Innnrtnal theraplt NA: not available ND: not done
rMolecular Anulyris in lhe nttutugemenl of Congenih! Adrenul Hyperplasia (CAH) and Atnbiguous Cenitqlia
On follow-up she had normal weight gain and
serum electrolytes. At 2 years of age there was
evidence of under treatment as there was an
acceleration in growth velocity. Bone age was
reported as between 6 to 9 months old. The dose of
cortisone acetate was increased to l0 mg/m2/day and
5 months later, it was further increased to 30 mg/m2/
day. Serum I7-OHP was monitored. Her bone age
at 6 years old was reported as 5 years and l0 months.
The blood pressure was normal except for a
borderline reading of l2O/70 mm Hg at 4 6/12 and
5 6/12 years old.
At6 5ll2 years old, she was admitted to our
centre for fever, vomiting and 3 episodes of fits.
Patient had hypotension and needed assisted
ventilation. She was managed as adrenal crisis and
meningitis' (Figure l). Her height was 110 cm (25-
50th percentile), weighr 20 kg (75-90th percentile).
She appeared muscular with hypertrophiecl clitoris
measuring 3.2 cm (Figure 2). During the course of
admission she was noted to have hypertension that
was initially attribured to the high dose of
intravenous hyd rocortisone.
An echocardiography performed revealed a
thickcned left ventricular wall with rcduced
contractility. Patient was thought to have a long-
standing hypertension. She was started on
antihypertensives and digoxin. Fludrocortisone was
discontinued. The results of molecular studies
showed a genotype of 46, XX and SRY gene was
not present. Ultrasound of the abdomen and pelvis
showed female internal reproductive system.
On follow-up, the serum electrolytes without
mineralocorticoid therapy were normal. Genitogram
of patient I (Figure 3) showed opacificarion of both
the bladder and vagina. The perineal opening
continued into a short segment urogenital sinus that
bifurcated just at the level of inferior pubic rami.
Clitoroplasty and vaginoplasty were performed.
Patient was maintained on glucocorticoids at a dose
of 16 mg/m2lday and her blood pressure readings
were normal.
Patient 2, was born full term by spontaneous
vaginal delivery at a district hospital with a birth
weight of 2.7 kg (25'h percentile). He was registered
as a boy at birth. On day 6 of life, he was referred to
HKB for severe neonatal jaundice that required
intensive phototherapy. Patient is the younger of 2
siblings and a product ofa consarguiueous urarriage.
During hospitalization, it was nored rhat
patient had an AG described as a prominent phallus,
hyperpigmented labioscrotal folds with a single
orifice at the base of the phallus and gonads were
not palpable. Initial serum electrolytes showed severe
Figure I: CT scan of ptttient l: Presence of meningeal
enhancement on Ihe right temporo-parietal region
sug gest ive of me ning it is.
Figure 2: External genitalia ofpatient I: Enlarged clitoris
of 3.2 cm.
Figure 3: Genitogram of patient l: The urinttry bladder
(UBD) andvagina (V) are opacified with a single perineal
opening.
hyponatraemia and hyperkalaemia, Based on the
clinical picture and electrolyte abnormality a
diagnosis of CAH was made. Patient was started on
glucocorticoid and mineralocorticoid. Hormonal
t<
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investigations showed elevated 17-OHP and ACTH
level. The testosterone was <20 ng/dl' Chrom,osome
analysis showed a 46, XX karyotype and SRY gene
*ur'no, present. The ultrasound of abdomen and
p"tui, t"u"ufed the presence of a uterus (Figure 4)
'and the genitogram demonstrated a normal urinary
Ui"ai"r 1"Hgut" Sl' Patient was re-assigned as female
ui ,tr" ug" Jf 6 months' Patient was first seen in our
centre it the age of 9 months' Weight was 6'4 kg
iio-zsrfr po""n1il";, h"ight 64'3 cm (5oth percentile)
and head circumference 42'5cm (25-50th percentile)'
The extemal genitalia was hyperpigmented over the
lubiu muioru.-Gonads were not palpable' The clitoris
*""rur"i 2.5 cm with a single orifice at its base'
Subsequent 17-OHP and testosterone level was
suppressed while on treatment' Further surgical
intervention was Planned'
Patient 3 was referred to our centre on Day l3
of life for further management of AG' Patient was born
full term by spontaneous vaginal delivery at a private
hospital *itft u Uitttt weight of 3' 1 kg (75'h percentile)'
The parents are non-consanguineous and patient has
un 
"id., sister who is healthy' 
Mother had a
-i*"ur.i"g" for the first pregnancy' On Day 5 of life
patient had hyponatraemia and hyperkalaemia' Based
on tt" clinical finding of ambiguous genitalia and
typical electrolyte changes, diagnosis of CAH was
nacle. Treatment was startcd with glucocorticoids and
mineralocorticoids after performing some hormonal
investigations- Ultrasound of the abdomen revealed
bilateral large adrenal glands and presence of a uterus'
On examination, the weight was 3'3 kg (75-
90'h percentile) and length 52 cm (>97'h percentile)'
naUy naa oral thrush andgreenish discharge from the
umbilicus. The external genitalia appeared feminine
with a clitoris measuring 0.9 cm in length' There was
slight hyperpigmentation and scrotalisation of the
mediat aspect of the labia majora' Gonads were not
palpable. There was no fusion of the labia minora and
ih"." *"r" 2 slit-like orifices seen representing the
urethra and vaginal orifices' The electrolytes while
patient *", on hormonal therapy showed nortnal
,".u* sodium and blood urea level with slight
hyperkalaemia (Table l)'
Patient was maintained on glucocorticoids and
mineralocorticoids pending results of horrnonal
investigations. A repeat ultrasound examlnatlon at our
centre ihowed presence of uterus, normal suprarenal
glands, dilatation of the pelvicalyceal system of both
fian"yt (FigureS) and mildly distended urinary
bladder. The urine exainination was normal and no
organisms were cultured' Umbilical swab showed a
mixed growth of Granr negative organism and thc full
blood picture showed reactive thrornbocytosis' The
l6
Fignre 4, (JS pelvis of patient2 showing the uterus (UT)'
urinary bladder (UBD)
Figure 6, Illrrasoundofthe kidnevs ofpatient j showing
h iitr t e ra I p e I v ic aly c e al s y s t e n d i! d t(tt i o tt ( c irc I e )'
serum testosterone level was slightly elevated according
to the a<lult female range. Serum I7-OHP level before
commencement of hormonal therapy was nortnal'
Aldosterone and plasma renin activity obtained when
patient was on mineralocorticoi<l therapy were still
"l"vate,l 
for age. Molecular studies confinlred that patient's
karyotype was 46 XX' SRY gene was not present'
Figrtre 5, Genitogram of patient 2, The urinary bladder(iStl) wa.s rtUed with contrast and norrnal in outline'
.1ffiIm
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Based on the results of investigations, the
glucocorticoids and mineralocorticoids were gradually
tapered and discontinued respectively. On fbllow-up,
the clitoris size normalized and the rugation of the
medial aspect of the labia majora disappeared.
Subsequent electrolytes values were within the normal
range. A repeat ultrasound of the urinary system one
month.later was reported as normal.
DISCUSSION
The presentation of the 3 patients illustrates
the problem encountered in managing AG/CAFI. The
diagnosis of CAH has to be suspected from the
physical appearance, symptoms or positive family
history. Investigations have to be done to confirm
the diagnosis of CAH and the genetic sex of the child.
Delay in <Jiagnosis and treatment of CAH lead to
the development of life threatening adrenal crisis as
in patients I and 2. Wrong gender assignment has
tragic consequences8. In a newborn baby with AG
urgent investigations are warranted. Sex assignment
should not be attempted based on appearance of
external genitalia. Patient 2 was wrongly assigned
as male and farnily had to sutTer the psychological
trauma of re-assignment as temale at the age ot b
months. Genetic sex of the 3 patients were
subsequently established using karyotyping and
cletermination of SRY genee.
Congenital adrenal hyperplasia was suspected
in patient 3 based on some ambiguity of the qxtemal
genitalia and electrolyte imbalances at the initial
presentation. After the relevant hormonal
investigations were taken, patient was started on
glucocorticoids and mineralocorticoids by the
attending paediatrician so as to prevent possible
adrenal crisis. There was elevated aldosterone level
and plasma renin activity despite treatment. The full
blood picture showed thrombocytosis and an umbilical
swab showed a mixed growth of gram negative bacilli
suggestive of possible infection. Urosepsis was ruled
out from the urine examination and culture. In view
of bilateral pelvicalyceal system dilatation and mildly
distended urinary bladder, a vesicoureteric reflux and
urinary tract infection were considered as possible
causes. However we could not confirm vesicoureteric
reflux on repeat ultrasound a month from presentation.
Infection probably causes unresponsiveness of the
distal renal tubules to aldo$terone, a condition known
as pseudohypoaldosteronismro' I r.
Imaging studies as ultrasound (US), computed
tomography (CT) scan and magnetlc resonance
image (MRI) of the abdomen/pelvis can aid in
Molecttlttr Attilysis irt lltt ilt(ututcnattt of Congenitol Adrcnul Hypetpkrsh (CALI) urul Ambiguous Genitaliu
identitying the uterus (Figure 4) and gonads. The latter
however may not be easily visualised. Genitogram
needs to be done to identify the anatomy of the
genitourinary system (Figure ]gnd 5) that is important
fbr future surgical correction of the external genitalia.
Clitoroplasty is usually performed in infancy but not
perfbrmed in patient I due to poor understanding of
the condition by the parcnts. Vaginoplasty with division
of the fused labial folds can be delayed until pubeny.
Close regular evaluation and dosage adjustment
of hormonal treatment especially glucocorticoids is
needed for a successful treatment. Under dosage of
glucocorticoids cause virilisation while over dosage
causes hypertension (patient l) and short stature as an
adult.
CONCT,USION
Molecular studies for SRY gene is one of the
tools for sex confinnation in addition to hormonal and
imaging studies in the evaluation of AG. Determination
of SRY gene may be helpful in sex determination and
gender assignment. It is a rapid and reliable technique
and will help the clinicians in making the right
rnanagement decision. Regular medical assessment and
Ittonlrurlttg ul' ttsa|rtrcul is lhu Luy to drc lluucuuulul
management of CAFVAG.
Molecular studies have enabled us to confirm
the sex of the 3 patients presenting with AG. It has aided
us in family counseling and further management
i ncluding the surgical correction of the extemal genitali a
as in paiient I and 2. Furthermore we could counsel"
the parents with regards to sex reassignment in our
second patient and prevent future virilisation and gender
crisis. As for patient 3, we were able to counsel the
parents who are anxious about the true gender of their
baby and the fact that she need not receive life-long
hormonal therapy. In the 3 patients that we managed,
the parents were content to have the problem rectified,
better understanding of the condition and to accept the
appropriate management.
In our experience with the cases of AG, we noted
that hormonal investigations should be done to conltrm
CAH and to include the molecular analyses as a
complementary tool in the battery of investigations'
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